Has Frances Bernasko received payments from drug or device companies?

Yes. Drug and device makers reported $916 in general payments to Frances Bernasko across 39 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Frances Bernasko did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Frances Bernasko come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Frances Bernasko

Psychiatric/Mental Health · Palm Beach Gardens, FLNPI 1386242329

Payments from drug & device makers

$916in general payments, 2019–2025

Across 39 payments — averaging $23.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$233
Teva Pharmaceuticals USA, Inc.$151
Alkermes, Inc.$104
Otsuka America Pharmaceutical, Inc.$88
Neurocrine Biosciences, Inc.$64
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$51
plus $224 from 7 others

What the payments were for

Food & beverage$80488%
Education$11112%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	9	$233
Teva Pharmaceuticals USA, Inc.	3	$151
Alkermes, Inc.	5	$104
Otsuka America Pharmaceutical, Inc.	5	$88
Neurocrine Biosciences, Inc.	3	$64
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	3	$51
Axsome Therapeutics, Inc.	2	$50
E.r. Squibb & Sons, L.L.C.	2	$46
Vanda Pharmaceuticals Inc.	2	$42
Collegium Pharmaceutical, Inc.	2	$33
Johnson & Johnson	1	$22
Takeda Pharmaceuticals U.S.A., Inc.	1	$16
Supernus Pharmaceuticals, Inc.	1	$15

How this compares

$916 in reported general payments places this provider in the 55th percentile of 3,096 psychiatric/mental health providers in Florida.

See all psychiatric/mental health providers in Florida →

Medicare billing

Part B allowed, 2024

$24,247

Medicare patients

175

Services billed

261

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Divalproex Sodium	41	$1,837
Divalproex Sodium ErDivalproex Sodium	12	$1,489
Quetiapine Fumarate	30	$857
Trazodone Hcl	42	$620
Duloxetine Hcl	14	$589
Clonazepam	21	$348
Lorazepam	14	$331
Temazepam	11	$186
Gabapentin	11	$84

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Palm Beach Gardens

Roger RiveraKissimmee$1.6M
Bethanie Simmons BecilJacksonville$782K
Hannah PhillipsMaitland$455K
Cheedy JajaTampa$266K
Scott DurrancePensacola$224K
Eudaldo AponteHialeah$214K
Heather WarrenTallahassee$172K
Angela DavenportAlachua$83K
Natalie MoodyWinter Haven$75K
Kelli BridgmanNew Smyrna Beach$66K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →